ResearcherMassachusetts Institute of TechnologyActive in the last 2 years

Phillip A. Sharp

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1465-1691; OpenAlex author ID A5022945869. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. Last author DOI 10.1016/j.immuni.2025.06.005 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Rakesh K. Jain · 1 shared paper, 2025 · strength 0.19
- Paper Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors… DOI 10.1016/j.immuni.2025.06.005 ↗
Dig Bijay Mahat · 1 shared paper, 2025 · strength 0.19
- Paper Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors… DOI 10.1016/j.immuni.2025.06.005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.